Phase 2 N=11 Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy
Progressive Supranuclear Palsy
Primary: Adverse Events — 23 Number of Adverse Events
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=72 Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Asthma
Primary: Standardized Baseline-Adjusted Area Under the Curve For Forced Expiratory Volume In 1 Second Over 12 Hours Post-dose (FEV1 AUC0-12) — 52.13; 203.84; 248.98; 279.69 mL…
Phase 2 N=20 Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Alcoholism · Schizophrenia
Primary: Self Reported Weekly Alcohol Consumption — 23.4; 19.6; 15.7; 10.0 percentage of days
Phase 2 N=121 Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Multiple Myeloma
Primary: Overall Response Rate — 6; 1; 20; 43 Participants
Phase 2 N=889 A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Asthma
Primary: Change From Baseline In Trough (Morning Predose And Pre-Rescue Bronchodilator) Forced Expiratory Volume In 1 Second (FEV1) Over The 12-Week Treatment Period — 0.059…
Phase 2 N=107 Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Skin Rash · Lung Cancer
Primary: Frequency of Participants Who Experienced Any Grade of Rash As Characterized By The Common Toxicity Criteria for Adverse Effects (CTCAE) V4.0 — 44.5; 75.5 Percentage of…
N/A N=24 Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Thyroid Cancer
Primary: Number of Patients Whose Tumor(s) Acquire an Increased Propensity for Iodine Uptake as Detected on Iodine-124 Positron Emission Tomography Scan — 12; 8 participants
Phase 2 N=7 Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
Diabetes Mellitus, Type 1
Primary: Insulin Independence. — 2 Participants
Phase 3 N=10 Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
Choroidal Melanoma
Primary: Mean Tumor Thickness — 2.91 mm
Phase 2 N=27 Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis (PSC)
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 1; 2; 2; 1 participant
Phase 3 N=245 Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.
Infections, Streptococcal · Streptococcus Pneumoniae Vaccines
Primary: Number of Subjects Reporting Fever With Rectal Temperature Above (>) 39.0 Degrees Celsius (°C) — 8; 6 Subjects
N/A N=62 Cast Immobilization for Non-Displaced Scaphoid Fractures
Non-displaced Scaphoid Fractures
Primary: Extent of Union — 70; 85 percentage of union
Phase 3 N=787 Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
Asthma
Primary: Standardized Baseline-Adjusted Forced Expiratory Volume in 1 Second (FEV1) Area Under the Effect Curve From Time Zero to 12 Hours Postdose (FEV1 AUEC0-12h) at Week 12…
N/A N=49 The Effect of Ultrasound on Orthodontic Tooth Movement
Malocclusion
Primary: Rate of Tooth Movement — 0.266; 0.232 mm/week — p=0.0164
Phase 2 N=312 Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers
Haemophilus Influenzae Type b · Tetanus · Hepatitis B
Primary: Number of Seroprotected Subjects Against Poliovirus Types 1, 2 and 3 — 78; 77; 78; 77 Participants